RBC Capital Maintains Outperform on Hinge Health, Raises Price Target to $75
Benzinga Newsdesk 4 months ago
NewsPrice TargetAnalyst Ratings
RBC Capital analyst Rishi Jaluria maintains Hinge Health (NYSE:HNGE) with a Outperform and raises the price target from $65 to $75.
RBC Capital analyst Rishi Jaluria maintains Hinge Health (NYSE:HNGE) with a Outperform and raises the price target from $65 to $75.